ERINHA launched a special SARS-Cov-2/COVID-19 call for free of charge Transnational Access (TNA) to its cutting-edge high containment and complementary facilities.
ERINHA Members – leading European high-containment facilities and world level experts – are highly involved both in diagnostics and research activities to tackle COVID-19 by developing and testing diagnostics, therapeutics and vaccines. Continue reading “10/04/2020 – ERINHA’s COVID-19 research activities”
Spotlight on ERINHA-Advance member, National Institute of Infectious Diseases (INMI) of Italy involved in CONVAT project.
ERINHA is involved in EUROCOVID project consortium recently submitted to IMI call “Development of therapeutics and diagnostics combatting coronavirus infections”. Continue reading “07/04/2020 – EUROCOVID consortium”
ERINHA welcomes its newest Member: The Rega Institute for Medical Research of the Katholieke Universiteit Leuven (KU Leuven), Belgium
“Rapid therapy development through Open Coronavirus Vaccine Platform” – Spotlight on ERINHA Swedish node research activities
CORBEL: A new website, lifescience-ri.eu, brings together the vast services of 13 Life Science Research Infrastructures
Continue reading “30/03/2020 – CORBEL: A new website”
ERINHA national node, INSERM’s BSL4 Laboratory Jean Mérieux provided a talk on Nipah virus research at the First REACTing Symposium on Emerging Infectious Diseases, held on November 21, 2019 at the Insitut Pasteur in Paris. Continue reading “2019/11/22 – First REACTing Symposium on Emerging Infectious Diseases”
The joint EDCTP and CEPI call on “Vaccines against Lassa virus disease” was launched to support distinct strategic actions (clinical research activities) which are part of efforts to prepare and conduct a large-scale clinical trial. The goal is to achieve proof of concept and/or demonstrate the efficacy of novel candidate vaccines against Lassa virus (LASV). Continue reading “2019/11/21 Vaccines against Lassa virus disease – Joint EDCTP and CEPI call”